Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Mayo Clinic Laboratories, |
RCV002284173 | SCV002573719 | likely pathogenic | not provided | 2021-09-13 | criteria provided, single submitter | clinical testing | PP1, PM2, PS3 |
Labcorp Genetics |
RCV002513077 | SCV003523192 | pathogenic | GLUT1 deficiency syndrome 1, autosomal recessive | 2023-08-04 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. Experimental studies have shown that this variant affects SLC2A1 function (PMID: 18451999). Algorithms developed to predict the effect of variants on protein structure and function are not available or were not evaluated for this variant. ClinVar contains an entry for this variant (Variation ID: 16112). This variant has been observed in individual(s) with SLC2A1-related conditions (PMID: 18451999, 25022942). In at least one individual the variant was observed to be de novo. It has also been observed to segregate with disease in related individuals. This variant is not present in population databases (gnomAD no frequency). This variant, c.843_854del, results in the deletion of 4 amino acid(s) of the SLC2A1 protein (p.Gln282_Ser285del), but otherwise preserves the integrity of the reading frame. |
Genome- |
RCV003445076 | SCV004172897 | likely pathogenic | Encephalopathy due to GLUT1 deficiency | 2023-04-11 | criteria provided, single submitter | clinical testing | |
OMIM | RCV000017492 | SCV000037764 | pathogenic | Childhood onset GLUT1 deficiency syndrome 2 | 2008-06-01 | no assertion criteria provided | literature only |